医药行业分析
- (2025-05-09)
- (2025-05-09)
- (2025-05-09)
- (2025-05-09)
- (2025-05-09)
- (2025-05-09)
- (2025-05-09)
- (2025-05-09)
- (2025-05-09)
- (2025-05-08)
- (2025-05-08)
- (2025-05-08)
- (2025-05-08)
- (2025-05-08)
- (2025-05-08)
- (2025-05-08)
- (2025-05-08)
- (2025-05-08)
腾盛博药在2025年EASL大会上公布了其正在进行的ENSURE 2期研究的最新突破数据,表明BRII-179在促进更高的HBsAg清除方面的作用
(2025-05-08)- (2025-05-08)
- (2025-05-07)
- (2025-05-07)
- (2025-05-07)
- (2025-05-07)
- (2025-05-06)
- (2025-05-06)
- (2025-05-06)
- (2025-05-06)
- (2025-05-06)
- (2025-05-06)
- (2025-05-06)
- (2025-05-06)
- (2025-05-06)
- (2025-05-05)
- (2025-05-05)
- (2025-05-04)
- (2025-05-04)
- (2025-05-03)
- (2025-05-03)
- (2025-05-03)
- (2025-05-03)
- (2025-05-02)
- (2025-05-02)
- (2025-05-02)
- (2025-05-02)
- (2025-05-01)
- (2025-05-01)
- (2025-04-30)
- (2025-04-30)
- (2025-04-30)
- (2025-04-30)
- (2025-04-30)
- (2025-04-30)
NEJM:肺癌患者出现这种情况很凶险!科学家发现,肿瘤浸润性克隆性造血与非小细胞肺癌患者的疾病复发或死亡风险增加80%有关
(2025-04-30)- (2025-04-30)
- (2025-04-29)
- (2025-04-29)
- (2025-04-29)
- (2025-04-29)
- (2025-04-29)